Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification

被引:2
作者
Bae, Bong Kyung [1 ]
Cho, Won Kyung [1 ]
Kim, Byoung-Gie [2 ]
Choi, Chel Hun [2 ]
Kim, Tae-Joong [2 ]
Lee, Yoo-Young [2 ]
Lee, Jeong-Won [2 ]
Park, Won [1 ]
机构
[1] Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[2] Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
关键词
Adenocarcinoma; Pathology; PELVIC RADIATION-THERAPY; RADICAL HYSTERECTOMY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; ADJUVANT THERAPY; UTERINE CERVIX; CARCINOMA; CANCER; CLASSIFICATION; INVASION;
D O I
10.1136/ijgc-2022-003971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveCervical adenocarcinoma has poorer outcomes compared with squamous cell carcinoma; however, treatment is identical irrespective of histologic sub-types. This study aimed to investigate the patterns and risk factors of recurrence following surgery alone for low-risk early-stage cervical adenocarcinoma. MethodsWe retrospectively reviewed patients who underwent surgery alone for low-risk early-stage cervical adenocarcinoma between January 2001 and December 2018 in a single institution. Baseline clinicopathological characteristics were collected to identify the factors associated with recurrence-free survival. ResultsA total of 252 patients met the inclusion criteria. Most patients underwent radical hysterectomy (218 patients, 86.5%) and had usual type endocervical adenocarcinoma (190 patients, 75.4%). The International Federation of Gynecology and Obstetrics 2018 stage was IA1 in 72 patients (27.4%), IA2 in 58 (22.1%), IB1 in 51 (19.4%), and IB2 in 71 patients (27.0%). With a median follow-up of 70.4 months (range 6.2-252.5 months), 5-year survival rates were as follows: locoregional recurrence-free survival, 93.0%; recurrence-free survival, 89.6%; overall survival, 94.7%. The recurrence patterns were local in nine patients (32.1%), regional in five patients (17.8%), distant in 10 patients (35.7%), local and distant in one patient (3.6%), regional and distant in two patients (7.2%), and locoregional and distant in one patient (3.6%). In multivariable analysis, negative human papillomavirus (HPV) status (HR 7.314; p<0.001) and deep cervical stromal invasion (HR 5.110; p=0.003) were associated with poor locoregional recurrence-free survival. Patients were stratified based on the number of risk factors and a statistically significant difference in locoregional recurrence-free survival was observed: 5-year survival rates of 99.0%, 84.2%, and 50.0% for patients with 0, 1, and 2 risk factors (0 vs 1, p=0.001; 1 vs 2, p=0.011). ConclusionSurgery alone for low-risk early-stage cervical adenocarcinoma was associated with favorable outcomes over a long follow-up period. Patients with the highest risk of recurrence were those with a negative HPV status and deep cervical stromal invasion. Additional management following surgery may be considered in patients with these risk factors.
引用
收藏
页码:1524 / 1530
页数:7
相关论文
共 50 条
[21]   Analysis of risk factors for patients with early-stage cervical cancer: A study of 374 patients [J].
Ueda, Kazu ;
Yanaihara, Nozomu ;
Iida, Yasushi ;
Kobayashi, Ritsuko ;
Kato, Sayako ;
Matsuda, Yuna ;
Tomita, Keisuke ;
Yamamura, Nami ;
Saito, Ryosuke ;
Hirose, Sou ;
Kuroda, Takafumi ;
Seki, Toshiyuki ;
Saito, Motoaki ;
Takano, Hirokuni ;
Yamada, Kyosuke ;
Okamoto, Aikou .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (01) :270-278
[22]   Survival outcomes of low-risk and intermediate-risk stage IB1 cervical cancer patients [J].
Vanichtantikul, Asama ;
Tantbirojn, Patou ;
Manchana, Tarinee .
ASIAN BIOMEDICINE, 2019, 13 (01) :27-32
[23]   Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer [J].
Dabi, Yohann ;
Willecoccq, Claire ;
Ballester, Marcos ;
Carcopino, Xavier ;
Bendifallah, Sofiane ;
Ouldamer, Lobna ;
Lavoue, Vincent ;
Canlorbe, Geoffroy ;
Raimond, Emilie ;
Coutant, Charles ;
Graesslin, Olivier ;
Collinet, Pierre ;
Bricou, Alexandre ;
Huchon, Cyrille ;
Darai, Emile ;
Haddad, Bassam ;
Touboul, Cyril .
JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
[24]   Tumor Necrotic Debris and High Nuclear Grade Newly Identified High-risk Factors for Early-stage Endocervical Adenocarcinoma [J].
Holloway, Steven B. ;
Colon, Glorimar R. ;
Zheng, Wenxin ;
Lea, Jayanthi S. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (04) :162-168
[25]   Analysis of the prognostic factors determining the oncological outcomes in patients with high-risk early-stage cervical cancer [J].
Kilic, Fatih ;
Cakir, Caner ;
Yuksel, Dilek ;
Korkmaz, Vakkas ;
Kimyon Comert, Gunsu ;
Boran, Nurettin ;
Koc, Sevgi ;
Turan, Taner ;
Turkmen, Osman .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (02) :281-288
[26]   Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors [J].
Yu, Hao ;
Zhang, Linlin ;
Du, Xuelian ;
Sheng, Xiugui .
ONCOTARGETS AND THERAPY, 2016, 9 :7331-7335
[27]   Clinical outcomes and recurrence patterns of high-intermediate-risk and high-risk early-stage endometrial cancer treated with postoperative intracavitary brachytherapy [J].
Yan, Zihan ;
Ren, Kang ;
Wang, Wenhui ;
Hu, Ke ;
Hou, Xiaorong ;
Zhang, Fuquan .
PRECISION RADIATION ONCOLOGY, 2023, 7 (03) :181-188
[28]   Risk Factors for Parametrial Involvement in Early-Stage Cervical Cancer and Identification of Patients Suitable for Less Radical Surgery [J].
Jiamset, Ingporn ;
Hanprasertpong, Jitti .
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) :432-438
[29]   Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts [J].
Zhou, Juntuo ;
Liu, Bing ;
Li, Zhongwu ;
Li, Yang ;
Chen, Xi ;
Ma, Yuanyuan ;
Yan, Shi ;
Yang, Xin ;
Zhong, Lijun ;
Wu, Nan .
MOLECULAR & CELLULAR PROTEOMICS, 2021, 20
[30]   Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors [J].
Seki, Toshiyuki ;
Tanabe, Hiroshi ;
Nagata, Chie ;
Suzuki, Jiro ;
Suzuki, Kayo ;
Takano, Hirokuni ;
Isonishi, Seiji ;
Ochiai, Kazuhiko ;
Takakura, Satoshi ;
Okamoto, Aikou .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (01) :32-38